Paradromics announced on 17 June 2026 that University of Michigan surgeons have implanted its Connexus brain-computer interface in a woman with motor neuron disease, the first patient in the FDA-approved Connect-One early feasibility study. She will be followed for six years.
San Francisco research lab Aleph Neuro published what it describes as the first 3D ultrasound localization microscopy (ULM) image of a living human brain through an intact skull on 24 June 2026, as a participant in Butterfly Network's Embedded licensing and co-development program.
A Stanford-led BrainGate study across eight paralysed participants and 20 microelectrode arrays, published in Nature on 17 June 2026, finds whole-body representation at every sampled location of the precentral gyrus.
Guangzhou and Shenzhen will split the work of building China's most ambitious provincial brain-computer interface industry under a 'Dual-Core' Action Plan released 24 June 2026: 10 billion yuan core industry, 100 new enterprises, 200 BCI hospital wards by 2030.
ActivateNeuro launched on 25 June 2026 with $2.9M and a license to Battelle's non-invasive NeuroLife sleeve, an sEMG-driven FES wearable for stroke and spinal cord injury hand rehabilitation.
Vice Premier Liu Guozhong inspected the Brain-Computer Interface Research Institute at Nanjing University on 22-23 June 2026, naming BCI a 'key area of international industrial competition' per Xinhua and NJU.
Singapore's Neural Drive raised a US$250K pre-seed from Afore Capital for a non-invasive EEG/EOG wearable designed for paralysed users, per a Singapore University of Technology and Design release on 23 June 2026.
Coherence Neuro placed its cancer-targeting brain-computer interface in three patients for 30 minutes during brain tumor resection at Royal Melbourne Hospital, with a permanent-implant glioblastoma trial planned for 2027.
Neuracle, maker of the world's first approved invasive BCI, had a RMB 2.5B Shanghai STAR Market IPO prospectus accepted on 11 June 2026, opening a two-horse race with BrainCo for first publicly listed pure-play BCI.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.